Impressive performance in an extraordinary year to date
Key takeaways
01
Biopharma investments are up, led by large mezz deals
IPO valuations and proceeds are on record pace and post-IPO stock performance has been incredible.
02
Dx/Tools are on track for record investment, four IPOs boasted $1B+ market caps at mid-year
Led by many companies leveraging their technologies to aid the COVID-19 response.
03
HealthTech led post-IPO performance with a $2B+ IPO that then increased its stock price by over 100%
Companies focused on providing alternative care outside the hospital raised 46% of capital in this sector.
The data
US healthcare venture capital fundraising
A flurry of venture fundraising in 1H 2020 nearly eclipsed 2019’s full-year record, $10.7B $10.4B building on a three-year trend of increased allocation to healthcare.
VC deals and dollars
The first half of 2020 produced the largest two-quarter investment total ever for venture-backed healthcare companies, despite financial market turbulence and setbacks to company product development, clinical trials, and revenues caused by COVID-19.
Biopharma Series A by top indications
Many venture investors have a bifurcated early-stage strategy, balancing internally-fashioned large Series A deals while supporting company creation and/or founder-led early-stage science.
HealthTech Series A by top subsectors
HealthTech Series A investments rose 40% and total funding increased by 20%, driven by deals in the alternative care, wellness & education, and clinical trial enablement (CTE) subsectors.
Dx/Tools and Device Series A by top indications
R&D Tools deals represented almost half of all Series A deal activity (48%). A number of these companies, are leveraging their technologies to aid the COVID-19 response.
Explore other Healthcare reports
Written and researched by SVB experts
Our deep relationships with top life science and healthcare entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank.
Stay up to date with SVB
Get our healthcare insights in your inbox
This material including, without limitation, to the statistical information herein, is provided for informational purposes only. The material is based in part on information from third-party sources that we believe to be reliable but which have not been independently verified by us, and for this reason, we do not represent that the information is accurate or complete. The information should not be viewed as tax, investment, legal or other advice, nor is it to be relied on in making an investment or other decision. You should obtain relevant and specific professional advice before making any investment decision. Nothing relating to the material should be construed as a solicitation, offer or recommendation to acquire or dispose of any investment or to engage in any other transaction.
Silicon Valley Bank, an authorized bank branch under the Bank Act (Canada).
SVB Financial Group UK Ltd is registered in England and Wales at Alphabeta, 14-18 Finsbury Square, London EC2A 1BR, UK under No. 5572575 and is authorised and regulated by the Financial Conduct Authority, with reference number 446159. Silicon Valley Bank and SVB Financial Group UK Limited are not licensed in Ireland to undertake banking business in Ireland or to undertake any other regulated activity in Ireland.
Silicon Valley Bank is registered in England and Wales at Alphabeta, 14-18 Finsbury Square, London EC2A 1BR, UK under No. FC029579. Silicon Valley Bank is authorised and regulated by the California Department of Business Oversight and the United States Federal Reserve Bank; authorised by the Prudential Regulation Authority with number 577295; and subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from us on request.
Silicon Valley Bank Germany Branch ist eine Zweigniederlassung der Silicon Valley Bank. Silicon Valley Bank, eine Aktiengesellschaft nach dem Recht des U.S. Bundesstaates Kalifornien, mit Sitz in Santa Clara, Kalifornien, U.S.A. ist eingetragen beim California Secretary of State unter der Nr. C1175907, Vorstand (Chief Executive Officer): Gregory W Becker, Aufsichtsratsvorsitzender (Chairman of the Board of Directors): Roger F Dunbar. Silicon Valley Bank Germany Branch mit Sitz in Frankfurt am Main ist eingetragen im Handelsregister des Amtsgerichts Frankfurt am Main unter der Nr. HRB 112038, Geschäftsleiter: Christian Hoppe, Dayanara Heisig. Silicon Valley Bank Germany Branch is a branch of Silicon Valley Bank.
Silicon Valley Bank, a public corporation with limited liability (Aktiengesellschaft) under the laws of the U.S. federal state of California, with registered office in Santa Clara, California, U.S.A. is registered with the California Secretary of State under No. C1175907, Chief Executive Officer (Vorstand): Gregory W Becker, Chairman of the Board of Directors (Aufsichtsratsvorsitzender): Roger F Dunbar.
Silicon Valley Bank Germany Branch with registered office in Frankfurt am Main is registered with the local court of Frankfurt am Main under No. HRB 112038, Branch Directors (Geschäftsleiter): Christian Hoppe, Dayanara Heisig.